Dx/Rx: Pancreatic Cancer

Dx/Rx: Pancreatic Cancer
Author: Maeve Lowery
Publisher: Jones & Bartlett Publishers
Total Pages: 126
Release: 2010-10-07
Genre: Medical
ISBN: 1449671594

Dx/Rx: Pancreatic Cancer was recently honored with 4 Stars from Doody's Book Review! Written by two expert oncologists specializing in pancreatic cancer, Dx/Rx: Pancreatic Cancer is a concise pocket reference for all professional caregivers of patients with pancreatic cancer. This handy guide provides comprehensive, up-to-date information on the epidemiology, symptoms, diagnosis, and management of malignancies of the pancreas. Topics include detailed outline of the diagnosis process and staging, molecular pathogenesis, localized diseases and advanced cases, metastatic pancreatic cancer, uncommon pancreatic malignancies, and information on supportive care. Presented in a quick-reference format, Dx/Rx: Pancreatic Cancer is an essential guide for on the ward or in the clinic.

Pancreatic Cancer

Pancreatic Cancer
Author: Douglas B. Evans
Publisher: Springer Science & Business Media
Total Pages: 413
Release: 2002
Genre: Medical
ISBN: 0387951857

The MD Anderson Solid Tumor Oncology series presents cutting-edge surgical treatment and medical therapy for specific sites. This volume, Pancreatic Cancer, addresses epidemiology and molecular biology, inherited syndromes, staging, surgical techniques, multimodality therapy, and emerging therapies. The individual chapters focus on narrow, specific topics to produce a reference work of value to those interested in pancreatic cancer from a clinical and translational research perspective. A must-have for surgical oncologists and general surgeons.

Dx/Rx: Liver Cancer

Dx/Rx: Liver Cancer
Author: Ghassan K. Abou-Alfa
Publisher: Jones & Bartlett Publishers
Total Pages: 167
Release: 2012-12-23
Genre: Medical
ISBN: 1449686176

Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver. Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Dx/Rx

Dx/Rx
Author: Ghassan K. Abou-Alfa
Publisher: Jones & Bartlett Publishers
Total Pages: 166
Release: 2013
Genre: Liver
ISBN: 1449646875

Physicians' Cancer Chemotherapy Drug Manual 2015

Physicians' Cancer Chemotherapy Drug Manual 2015
Author: Edward Chu
Publisher: Jones & Bartlett Publishers
Total Pages: 682
Release: 2014-12-22
Genre: Medical
ISBN: 1284075214

Completely revised and updated for 2015, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. SPECIAL FEATURES: -Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. -A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. -Diagrams of drug structures and pathways for many of the agents. -Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. -Covers toxicity and drug-drug interactions. -A section on chemotherapy regimens for all major cancers. -Provides an overview of the basic principles of cancer drug therapy.

Physicians' Cancer Chemotherapy Drug Manual 2017

Physicians' Cancer Chemotherapy Drug Manual 2017
Author: Edward Chu
Publisher: Jones & Bartlett Learning
Total Pages: 616
Release: 2016-12-16
Genre: Medical
ISBN: 1284124479

Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.

Physicians' Cancer Chemotherapy Drug Manual 2018

Physicians' Cancer Chemotherapy Drug Manual 2018
Author: Edward Chu
Publisher: Jones & Bartlett Learning
Total Pages: 655
Release: 2017-12
Genre: Medical
ISBN: 1284144968

Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2018 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.

Physicians' Cancer Chemotherapy Drug Manual 2014

Physicians' Cancer Chemotherapy Drug Manual 2014
Author: Edward Chu
Publisher: Jones & Bartlett Publishers
Total Pages: 672
Release: 2014-03-21
Genre: Medical
ISBN: 1284026868

Completely revised and updated for 2014, the Physicians' Cancer Chemotherapy Drug Manual 2014 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. Special features: - Revised to reflect rapid advances in the field - A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. - Diagrams of drug structures and pathways for many of the agents. - Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. - Covers toxicity and drug-drug interactions. - A section on chemotherapy regimens for all major cancers. - Provides an overview of the basic principles of cancer drug therapy.

Physicians' Cancer Chemotherapy Drug Manual 2013

Physicians' Cancer Chemotherapy Drug Manual 2013
Author: Edward Chu
Publisher: Jones & Bartlett Publishers
Total Pages: 630
Release: 2012-12-28
Genre: Medical
ISBN: 1284040399

Completely revised and updated for 2013, the Physicians’ Cancer Chemotherapy Drug Manual 2013 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. Special features: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like brentuximab, carfilzomib, crizotinib, pertuzumab, rogorafenib, vemurafenib, and vismodegib. • A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. • Covers toxicity and drug–drug interactions. • A section on chemotherapy regimens for all major cancers. • Provides an overview of the basic principles of cancer drug therapy. • Contains an easy to load and use CD version. Mobile version of Physicians’ Cancer Chemotherapy Drug Manual also available!

Physicians' Cancer Chemotherapy Drug Manual 2016

Physicians' Cancer Chemotherapy Drug Manual 2016
Author:
Publisher: Jones & Bartlett Publishers
Total Pages: 567
Release: 2015-12-30
Genre: Medical
ISBN: 1284079872

Completely revised and updated for 2016, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like belinostat, blinatumomab, lenvatinib, nivolumab, olaparib, palbociclib, panobinostat, pembrolizumab, and ramucirumab • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. • Covers toxicity and drug–drug interactions. • A section on chemotherapy regimens for all major cancers. • Provides an overview of the basic principles of cancer drug therapy.